RELAY: Final Overall Survival for Erlotinib + Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC von Nakagawa, Kazuhiko, Garon, Edward B, Seto, Takashi, Nishio, Makoto, Aix, Santiago Ponce, Paz-Ares, Luis, Chiu, Chao-Hua, Park, Keunchil, Novello, Silvia, Nadal, Ernest, Nishino, Kazumi, Yoh, Kiyotaka, Shih, Jin-Yuan, Chik, Jeannie Yk, Moro-Sibilot, Denis, Puri, Tarun, Varughese, Sunoj Chacko, Frimodt-Moller, Bente, Visseren-Grul, Carla, Reck, Martin

Volltext